BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 3297327)

  • 21. Anti-idiotypic antibodies in the study and treatment of experimental autoimmune myasthenia gravis.
    Souroujon MC; Fuchs S
    Methods Enzymol; 1989; 178():433-48. PubMed ID: 2601627
    [No Abstract]   [Full Text] [Related]  

  • 22. Lack of inter-animal cross-reaction of anti-acetylcholine receptor antibodies at the receptor-binding site as demonstrated by heterologous anti-idiotype antisera: implications for immunotherapy of myasthenia gravis.
    Barkas T; Simpson JA
    Clin Exp Immunol; 1982 Jan; 47(1):119-26. PubMed ID: 7094417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The start of an autoimmune disease: idiotypic network during early progression of myasthenia gravis.
    Lefvert AK
    Ann Inst Pasteur Immunol; 1988; 139(6):633-43. PubMed ID: 3264703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological similarities between an experimental autoimmune myasthenia gravis model and human myasthenia gravis.
    Souan ML; Geffard M
    Neurosci Lett; 1986 Aug; 68(3):282-7. PubMed ID: 2427976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A possible cause of myasthenia gravis: idiotypic networks involving bacterial antigens.
    Dwyer DS; Vakil M; Bradley RJ; Oh SJ; Kearney JF
    Ann N Y Acad Sci; 1987; 505():461-71. PubMed ID: 2446558
    [No Abstract]   [Full Text] [Related]  

  • 26. [Plasma exchange in myasthenia gravis].
    Redeker M; Meyer-Wahl L
    Nervenarzt; 1982 Dec; 53(12):729-32. PubMed ID: 7155236
    [No Abstract]   [Full Text] [Related]  

  • 27. Idiotypic network in myasthenia gravis demonstrated by human monoclonal B-cell lines.
    Lefvert AK; Holm G
    Scand J Immunol; 1987 Nov; 26(5):573-8. PubMed ID: 3500505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunochemical analysis of acetylcholine receptor and its relevance to specific treatment of experimental autoimmune myasthenia gravis.
    Fuchs S
    Adv Cytopharmacol; 1979; 3():279-85. PubMed ID: 382790
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum Acetylcholine Receptor Antibodies Before the Clinical Onset of Myasthenia Gravis.
    Strijbos E; Verschuuren JJGM; Kuks JBM
    J Neuromuscul Dis; 2018; 5(2):261-264. PubMed ID: 29865092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human x human hybridomas from patients with myasthenia gravis: possible tools for idiotypic therapy for myasthenia.
    Blair DA; Mihovilovic M; Agius MA; Fairclough RH; Richman DP
    Ann N Y Acad Sci; 1987; 505():155-67. PubMed ID: 3500665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunopathogenesis and treatment of myasthenia gravis.
    Levinson AI; Zweiman B; Lisak RP
    J Clin Immunol; 1987 May; 7(3):187-97. PubMed ID: 3036906
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-idiotypic antibodies to anti-acetylcholine receptor antibody: characterization by ELISA and immunoprecipitation assays.
    Pachner AR; Sourojon M; Fuchs S
    J Neuroimmunol; 1986 Sep; 12(3):205-14. PubMed ID: 3488332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-acetylcholine and anti-receptor antibodies in myasthenia].
    Lebrun-Grandie P; Souan ML; Geffard M; Dartigues JF; Mauricet B; Orgogozo JM
    Presse Med; 1987 Oct; 16(32):1577-80. PubMed ID: 2958833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Myasthenia, a model of a disease caused by auto-antibodies].
    Goulon M; Gajdos P; Goulon-Goëau C
    Ann Med Interne (Paris); 1987; 138(6):444-61. PubMed ID: 2829682
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-acetylcholine receptor antibodies induced in mice by syngeneic receptor without adjuvants.
    Scadding GK; Calder L; Vincent A; Prior C; Wray D; Newsom-Davis J
    Immunology; 1986 May; 58(1):151-5. PubMed ID: 3486818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-idiotypic antibodies against the receptor antibodies in myasthenia gravis.
    Lefvert AK
    Scand J Immunol; 1981; 13(5):493-7. PubMed ID: 7313551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular production of antibodies related to the acetylcholine receptor in myasthenia gravis: correlation with clinical stage.
    Lefvert AK; Holm G; Sundén H; Pirskanen R
    Scand J Immunol; 1987 Mar; 25(3):265-73. PubMed ID: 2436288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment.
    Pachner AR
    Yale J Biol Med; 1987; 60(2):169-77. PubMed ID: 3495075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptors in immunology.
    Gmelig Meyling FH
    Neth J Med; 1985; 28(2):63-8. PubMed ID: 3919325
    [No Abstract]   [Full Text] [Related]  

  • 40. [Determination of anti-acetylcholine receptor antibodies in myasthenia and its treatment by plasma exchange and immunosuppressants].
    Goulon M; Gajdos P; Goulon C; Bussel A; Morel E; Raimond F; Estournet B
    C R Seances Soc Biol Fil; 1980; 174(4):467-78. PubMed ID: 6449232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.